country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-N19854

Copy Link Print Information

Mariaterpenoside A

Mariaterpenoside A is an inducible nitric oxide synthase (iNOS) inhibitor. Mariaterpenoside A interacts with the active cavity of iNOS protein via hydrogen bonds with specific residues of the binding site. Mariaterpenoside A suppresses NO release in LPS (HY-D1056)-induced murine microglial BV-2 cells. Mariaterpenoside A can be used for the research of neurodegenerative disease.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 2097442-40-3
Formel: C₁₆H₂₄O₈
Molecular Weight:344.36

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

Mariaterpenoside A Chemical Structure

CAS. Nr.: 2097442-40-3

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- IC₅₀ & Target
- Cellular Effect
- In Vitro
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

IC₅₀ & Target

^[1]

iNOS

Alle NO Synthase Isoform-spezifische Produkte anzeigen :

Cellular Effect

Cell Line	Type	Value	Description	References
BV-2	IC₅₀	14.1 μM Compound: 3	Inhibition of LPS-induced NO production in mouse BV2 cells after 20 hrs by Griess assay Inhibition of LPS-induced NO production in mouse BV2 cells after 20 hrs by Griess assay	[PMID: 28377060]

In Vitro

Mariaterpenoside A (Compound 3) potently inhibits LPS-induced NO production in murine microglial BV-2 cells with an IC₅₀ of 14.1 μM without significant cytotoxicity^[1].
Mariaterpenoside A interacts with the active cavity of iNOS protein (PDB code: 3E6T) with a binding energy of -8.28 kcal/mol, targeting residues GLY-365, TYR-367, GLU-371, PRO-344, and TRP-366^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Related Protocols :

Research Protocol for Neurological Diseases

Chemical Information

CAS. Nr. 2097442-40-3
Molecular Weight 344.36
Formel C₁₆H₂₄O₈
SMILES

O[C@H]1[C@H](OC2=C(CO)C=CC(C(C)(C)O)=C2)O[C@H](CO)[C@@H](O)[C@@H]1O
Structure Classification
- Saccharides
- Monosaccharides
Initial Source
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Handling Instructions (2659 KB)

Verweise

[1]. Qin NB, et al. Bioactive terpenoids from Silybum marianum and their suppression on NO release in LPS-induced BV-2 cells and interaction with iNOS. Bioorg Med Chem Lett. 2017;27(10):2161-2165. [Content Brief]

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen